CXCL1-induced, neutrophil-driven liver damage further led to inflammatory and fibrogenic processes and facilitated the progression of NASH; the expression profiles of the genes involved in inflammation and fibrosis were similar to those found in NASH patients (16). This evidence concerns the gene CXCL1 and metabolic dysfunction-associated steatohepatitis.